Comparison of cytogenetics with FISH in 40 myelodysplastic syndrome patients

Leukemia Research

Volumn 26, Issue 11, 2002, Pages 993-996

  Romeo, Maura ^a   Chauffaille, Maria De Lourdes ^a   Silva, Maria Regina R ^a   Bahia, Daniella M M ^a   Kerbauy, José ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

FISH; Karyotype; Myelodysplastic syndrome

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; INTERMETHOD COMPARISON; INTERPHASE; KARYOTYPE 46,XX; KARYOTYPE 46,XY; KARYOTYPING; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 5; CHROMOSOMES, HUMAN, PAIR 7; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROGNOSIS;

EID: 0036842341     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(02)00047-4     Document Type: Article

References (19)

1. Bennet J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A.G., Gralnick H.R.et al. (FAB cooperative group) - Proposals for classification of the myelodysplastic syndrome. Br. J. Haematol. 51:1982;189-199.
2. Harris N.L., Jaffe E.S., Diebold J., Flandrin G., Muller-Hermelink K., Vardiman J.et al. World health organization classification of neoplastic diseases of the hematopoietic, World health organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committe meeting - Airlie House, Virginia, November 1997. J. Clin. Oncol. 17(12):1999;3835-3849.
3. Fenaux P., Morel P., Lai J.L. Cytogenetics of myelodysplastic syndromes. Semin. Haemotol. 33(2):1996;127-138.
4. Bernell P., Jacobsson B., Nordgren A., Hast R. Clonal cell lineage involvement in myelodysplastic syndrome studied by fluorescence in situ hybridization and morphology. Leukemia. 10:1996;662-668.
5. Anastasi J., Feng J., Le Beau M.M., Larson R.A., Rowley J.D., Vardiman J.W. Cytogenetic clonality in myelodysplastic syndrome studied with fluorescence in situ hybridization: lineage, response to growth factor therapy, and clone expansion. Blood. 81(6):1993;1580-1585.
6. Greenberg P., Cox C., Le Beau M.M., Fenaux P., Morel P., Sanz G.et al. International scoring system for evaluating prognosis in myelodysplastic syndrome. Blood. 89(6):1997;2079-2088.
7. Luke S., Varkey J.A., Belogolovkin V., Ladoulis C.T. Current state of fluorescence in situ hybridization (FISH) in diagnostic pathology. Cell Vision. 4(7):1997;16-31.
8. Gozzetti A., Le Beau M.M. Fluorescence in situ hybridization. Uses and limitations. Semin. Hematol. 37(4):2000;320-333.
9. Jenkins R.B., Le Beau M.M., Kraker W.J., Borell T.J., Stalboerger P.G., Davis E.M.et al. Fluorescence in situ hybridization: a sensitive method for trisomy 8 detection in bone marrow specimens. Blood. 79(12):1992;3307-3315.
10. Zhao L., Oort J.V., Cork A., Liang J.C. Comparison between interphase and metaphase cytogenetics in detecting chromosome defects in hematological neoplasias. Am. J. Hematol. 43:1993;205-211.
11. Kibbelar R.E., Mulder J.W.R., Dreef E.J., Van Kamp H., Fibbe W.E., Wessels J.W.et al. Detection of monosomy 7 and trisomy 8 in myeloid neoplasia: a comparison of banding and fluorescence in situ hybridation. Blood. 82(3):1993;904-913.
12. Tanaka K, Arif M, Eguchi M, Shintani MM, Kumaravel T.S., Asaoku H, et al. Interphase flurescence in situ hybridization overcomes pitfalls of G-banding analysis with special references to underestimation of chromomal aberration rates, Cancer Genet Cytogenet 1999;115:32-8.
13. Schröck E, Padilla-Nash H. Spectral karyotyping and multicolor fluorescence in situ hybridization reveal new tumor-specific chromosomal aberration. Semin. Hematol 2000;37(4):334-47.
14. Engel H., Drach J., Keyhani A., Jiang S., Van N.T., Kimmel M.et al. Quantitation of minimal residual disease in acute myelogenous leukemia and myelodysplastic syndrome in complete remission by molecular cytogenetics of progenitor cells. Leukemia. 13:1999;568-577.
15. Chauffaille M.L., Figueiredo M.S., Beltrani R., Antunes S.V., Yamamoto M., Kerbauy J. Acute promyelocytic leukemia: the sutdy of t(15;17) translocation by FISH, RT-PCR and cytogenetic techniques. Braz. J. Med. Biol. Res. 34(6):2001;735-743.
16. F. Mitelman, editor. ISCN: An International System for Human Cytogenetic Nomenclature. Basel: S. Karger, 1995.
17. Raynaud S.D., Baens M., Grosgeorge J., Rodgers K., Reid C.D.L., Daiton M.et al. Fluorescence in situ hybridization analysis of t(3;12)(q26;q13): a recurring chromosomal abnormality involving the TEL gene (ETV6) in myelodysplastic synrome. Blood. 88(2):1996;682-689.
18. Geddes A.D., Bowen D.T., Jacobs A. Clonal karyotype abnormalities and clinical progress in the myelodysplastic syndrome. Br. J. Haematol. 76:1990;194-202.
19. Harbott J., Mancini M., Verellen-Dumoullin C.H., Moorman A.V., Secker-Walker L.M. Hematological malignancies with a deletion of 11q23: cytogenetic and clinical aspects. Leukemia. 12:1998;823-827.